KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $16.79 $21.89 Friday, 26th Apr 2024 KURA stock ended at $19.65. This is 3.42% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.01% from a day low at $18.95 to a day high of $19.71.
90 days $16.79 $24.16
52 weeks $7.41 $24.16

Historical Kura Oncology prices

Date Open High Low Close Volume
Jan 09, 2024 $15.08 $15.08 $14.67 $14.87 667 493
Jan 08, 2024 $14.81 $15.46 $14.81 $15.32 1 182 059
Jan 05, 2024 $15.49 $15.53 $14.99 $15.00 558 434
Jan 04, 2024 $14.97 $15.85 $14.97 $15.63 1 491 074
Jan 03, 2024 $15.46 $15.46 $14.85 $15.06 863 468
Jan 02, 2024 $14.47 $15.49 $14.39 $15.36 995 759
Dec 29, 2023 $14.29 $14.64 $14.16 $14.38 660 234
Dec 28, 2023 $14.25 $14.47 $14.02 $14.31 423 757
Dec 27, 2023 $14.08 $14.23 $13.93 $14.22 313 486
Dec 26, 2023 $13.99 $14.14 $13.67 $14.01 384 278
Dec 22, 2023 $13.25 $13.91 $13.11 $13.69 914 569
Dec 21, 2023 $12.63 $12.75 $12.30 $12.57 445 123
Dec 20, 2023 $13.26 $13.37 $12.33 $12.35 607 256
Dec 19, 2023 $12.45 $13.50 $12.45 $13.29 2 758 840
Dec 18, 2023 $12.27 $12.54 $11.96 $12.35 1 130 780
Dec 15, 2023 $12.07 $12.36 $11.97 $12.30 2 816 688
Dec 14, 2023 $11.80 $12.25 $11.61 $11.95 1 652 891
Dec 13, 2023 $11.13 $11.61 $10.88 $11.60 1 292 842
Dec 12, 2023 $10.66 $11.49 $10.37 $11.13 3 019 893
Dec 11, 2023 $10.72 $10.95 $10.44 $10.72 1 804 429
Dec 08, 2023 $11.27 $11.44 $10.40 $10.81 1 015 380
Dec 07, 2023 $11.16 $11.43 $11.04 $11.30 778 280
Dec 06, 2023 $10.90 $11.48 $10.81 $11.07 1 057 741
Dec 05, 2023 $10.09 $10.90 $10.08 $10.80 522 788
Dec 04, 2023 $9.92 $10.21 $9.80 $10.21 417 233
Click to get the best stock tips daily for free!

About Kura Oncology

Kura Oncology Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, includi... KURA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT